Hoya Corp. (OTCMKTS:HOCPY - Get Free Report) was the recipient of a significant increase in short interest during the month of July. As of July 31st, there was short interest totaling 39,500 shares, anincreaseof291.1% from the July 15th total of 10,100 shares. Based on an average daily volume of 81,500 shares, the days-to-cover ratio is presently 0.5 days. Approximately0.0% of the shares of the company are short sold. Approximately0.0% of the shares of the company are short sold. Based on an average daily volume of 81,500 shares, the days-to-cover ratio is presently 0.5 days.
Analyst Ratings Changes
HOCPY has been the topic of several analyst reports. The Goldman Sachs Group upgraded Hoya from a "hold" rating to a "strong-buy" rating in a report on Wednesday, July 23rd. Erste Group Bank upgraded Hoya from a "hold" rating to a "strong-buy" rating in a report on Friday, May 23rd.
Read Our Latest Analysis on HOCPY
Hoya Stock Down 2.8%
Shares of OTCMKTS HOCPY opened at $130.54 on Friday. The stock has a market cap of $44.79 billion, a PE ratio of 32.64, a price-to-earnings-growth ratio of 2.68 and a beta of 0.91. The company has a quick ratio of 4.21, a current ratio of 4.90 and a debt-to-equity ratio of 0.03. Hoya has a 52-week low of $97.49 and a 52-week high of $148.27. The business has a 50-day moving average price of $121.94 and a 200 day moving average price of $119.82.
Hoya (OTCMKTS:HOCPY - Get Free Report) last posted its quarterly earnings data on Friday, August 1st. The technology company reported $1.05 earnings per share for the quarter, topping analysts' consensus estimates of $1.04 by $0.01. The company had revenue of $1.53 billion during the quarter, compared to analysts' expectations of $1.47 billion. Hoya had a return on equity of 21.24% and a net margin of 23.57%. Equities research analysts forecast that Hoya will post 3.66 earnings per share for the current year.
Hoya Company Profile
(
Get Free Report)
HOYA Corporation, a med-tech company, provides high-tech and medical products worldwide. It operates through three segments: Life Care, Telecommunication, and Other. The company offers life care products, including eyeglass and contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment; and other medical related products, such as prosthetic ceramic fillers and metallic implants for orthopedics.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Hoya, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hoya wasn't on the list.
While Hoya currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.